Jeffrey J. Zuravleff

Author

University of Pittsburgh Medical Center

Also Known As

J J Zuravleff, J. J. Zuravleff, JEFFREY J. ZURAVLEFF, Jeffrey J. Zuravleff, Jeffrey John Zuravleff, Jeffrey Zuravleff

Publications

Citations

H-Index

Concepts

All Affiliations

University of Pittsburgh Medical Center United States Department of Veterans Affairs University of Pittsburgh

About

Jeffrey J. Zuravleff is an author at University of Pittsburgh Medical Center specializing in medicine, clinical microbiology, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	1.7K
2	Health Sciences	5	5	580
3	Epidemiology	2	2	226
4	Public Health	1	1	36
5	Biochemistry	1	1	10

Jeffrey J. Zuravleff

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Antibiotic therapy for Pseudomonas aeruginosa bacteremia: Outcome correlations in a prospective study of 200 patients Megan Hilf, Victor L. Yu, Joann Sharp, The American Journal of Medicine Antimicrobial SusceptibilityAntibioticsAntimicrobial TherapyMicrobiologyAntimicrobial Agents	1989	554
<i>Staphylococcus aureus</i>Nasal Carriage and Infection in Patients on Hemodialysis Victor L. Yu, Angella Goetz, Marilyn M. Wagener, New England Journal of Medicine HemodialysisHealth SciencesAntibioticsAntimicrobial StewardshipMedicine	1986	485
Intraocular Candidiasis in Patients with Candidemia Sean P. Donahue, Craig M. Greven, Jeffrey J. Zuravleff, Ophthalmology Diagnostic MycologyOphthalmologyVaginitisClinical MycologyOcular Pathology	1994	238
Ubiquitousness of<i>Legionella pneumophila</i>in the Water Supply of a Hospital with Endemic Legionnaires' Disease Janet E. Stout, Victor L. Yu, Richard M. Vickers, New England Journal of Medicine Legionella PneumophilaDisease OutbreakBacterial PathogensHealthcare-associated InfectionEmerging Infectious Disease	1982	190
Diagnosis of Legionnaires' disease. An update of laboratory methods with new emphasis on isolation by culture Jeffrey J. Zuravleff JAMA	1983	76
Antibiotic therapy for pseudomonas aeruginosa bacteremia: Outcome correlations in a prospective study of 200 patients Megan Hilf, Victor L. Yu, Joann Sharp, The American Journal of Medicine Antimicrobial SusceptibilityAntibioticsAntimicrobial TherapyMicrobiologyAntimicrobial Agents	1989	50
Comparative susceptibilities of Pseudomonas aeruginosa to 1-oxacephalosporin (LY 127935) and eight other antipseudomonal antimicrobial agents (old and new) Victor L. Yu, Richard M. Vickers, Jeffrey J. Zuravleff Antimicrobial Agents and Chemotherapy Antipseudomonal AntibioticsAntimicrobial SusceptibilityHealth SciencesAntibioticsMedicine	1980	39
Lack of Evidence for Person-to-Person Transmission of Legionnaires' Disease Victor L. Yu, Jeffrey J. Zuravleff, L. Gavlik, The Journal of Infectious Diseases Infectious Disease EpidemiologyPerson-to-person TransmissionPathogenesisClinical EpidemiologyHealthcare-associated Infection	1983	36
Intraocular distribution of intravitreally administered amphotericin B in normal and vitrectomized eyes. Lemuel B. Wingard, Jeffrey J. Zuravleff, Bernard H. Doft, PubMed Intraocular DistributionOcular DiseaseVitrectomized EyesVitreous BodyOphthalmology	1989	31
Addition of rifampin to carboxypenicillin-aminoglycoside combination for the treatment of Pseudomonas aeruginosa infection: clinical experience with four patients Victor L. Yu, Jeffrey J. Zuravleff, James E. Peacock, Antimicrobial Agents and Chemotherapy Antimicrobial ChemotherapyClinical ExperienceDrug ResistancePseudomonas Aeruginosa InfectionCarboxypenicillin-aminoglycoside Combination	1984	23

Page 1